DCGI nod to export of nearly 2L Serum's malaria vaccine
Premium- This vaccine is developed by scientists at the University of Oxford and manufactured by Serum Institute in the UK
The Drugs Controller General of India (DCGI) will allow the export of approximately 2 lakh doses of Malaria vaccine which is produced in India. This vaccine is developed by scientists at the University of Oxford and manufactured by Serum Institute in the UK, sources close to the development have revealed.
The move comes after an application was submitted by Prakash Kumar Singh, director, Government and Regulatory Affairs, at Serum Institute of India (SII) to DCGI on September 27 seeking permission to export the vaccine against malaria, official sources told PTI.
"SII has developed the vaccine against malaria under leadership of our CEO Dr Adar C Poonawalla. We have been relentlessly working to make available made-in-India and world-class vaccines against malaria to our country and world at large," an official source quoted Singh as having said in the application.
The malaria vaccine was designed at the Jenner Institute, University of Oxford, which collaborated with the SII in 2020 to manufacture and develop the jab for large- scale supply, the sources said.
The vaccine trial results which included 409 children in Nanoro, Burkina Faso showed that three initial doses followed by a booster after a year gives up to 80 per cent protection against the disease, they said.
Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
More Less